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including type 2 diabetes (T2D) and stroke (4,5); in contrast, individuals with higher gluteal adiposity 13 have lower risk of such outcomes.(5) Previous studies indicate that fat distribution, as assessed by 14 waist-to-hip ratio (WHR), is a trait with a strong heritable component, independent of overall adiposity 15 (measured by BMI) (5, 6) , and recent Mendelian randomisation studies using known WHR-associated 16 genetic variants showed putative causal effects of higher WHR on T2D and coronary artery disease 17 independently of BMI (7).
19
With the goal of pinpointing genetic variants associated to body shape and fat distribution, and 20 motivated by the recent release of genetic data from half a million individuals (8), we performed a 21 meta-analysis of WHR adjusted for BMI (WHRadjBMI) . WHRadjBMI is an easily-measured fat distribution 22 phenotype that correlates well with imaging-based fat distribution measures (9). We performed 23 genome-wide association studies (GWAS) of WHRadjBMI in the UK Biobank data set (8), a collection of 24 484,563 samples with densely-imputed genotype data, using a linear mixed model (10) to account for 25 relatedness and ancestral heterogeneity. We then combined the results with publicly-available GWAS 26 data generated by the GIANT consortium for the same phenotype (Table 1 and Methods) (5), resulting 27 in a meta-analysis of 694,649 samples ( Table 1 ) and ~27.4M SNPs (Methods). As a sensitivity analysis 28 and to evaluate the robustness of our results, we also performed a GWAS of WHR unadjusted for BMI 29 (Table 1) .
31
We identified 346 loci (300 novel) containing 463 independent signals associated with WHRadjBMI (p < 5 32 x 10 -9 , to account for the denser imputation data (11); Methods, Supplementary Table 1 and 33 Supplementary Fig 1) . The Linkage Disequilibrium (LD) Score Regression (12) intercept (1.035) of the 34 meta-analysis results indicated that the observed enrichment in genomic signal was due to polygenicity 35 and not confounding ( Supplementary Table 2 ). Of the 300 novel signals, 234 (78%, pbinomial < 1 x 10 -7 ) 36 were directionally-consistent in an independent dataset with a relatively small sample size (N = 7,721) 37 4 and signals were consistent in several sensitivity checks ( Supplementary Tables 3-5, and 1 Supplementary Fig 2-3) . Combined, these variants explained ~3.9% of the variance in WHRadjBMI in 2 the independent study (Methods and Table 1 ). We constructed a weighted polygenic risk score using 3 the 346 index SNPs discovered in the combined meta-analysis and tested this score in the same 4 independent study. The 5% of individuals carrying the most WHRadjBMI-raising alleles were 5 approximately 1.62 times more likely to meet the WHR threshold for metabolic syndrome (13) than the 6 5% carrying the fewest (consistent with the results obtained from unweighted polygenic score; 7 Methods).
9
A number of analyses indicated that the majority of signals identified have genuine effect on body 10 shape, and that any bias caused by adjusting WHR for a correlated covariate (14, 15) (that is, BMI) was 11 minimal. Of the 346 index variants, 311 associated with stronger standard deviation effect sizes for 12 WHR (unadjusted) than with standard deviation effect sizes for BMI ( Supplementary Table 3 and 13 Supplementary Fig 4) . This observation also indicates that the WHR association is unlikely to be 14 secondary to the known effect of higher BMI resulting in higher WHR. Furthermore, the common SNP 15 associated with the largest known effect on BMI, that in the FTO gene (16), was not associated with 16 WHRadjBMI (rs1421085, p = 0.40) despite a very strong association with WHR (p = 4 x 10 -118) ). Finally, 17 carrying each additional (weighted) WHRadjBMI-raising allele was associated with an increase in 18 WHRadjBMI of 0.0199 SD (p = 6 x 10 -62 ; adjusted R 2 = 4%), an increase in WHR of 0.0111 SD (p = 3 x 10 -19 20 ; adjusted R 2 = 0.12%) and a decrease in BMI of 0.0038 SD (p = 1.4 x 10 -3 ; adjusted R 2 = 0.13%) in our 20 independent dataset, consistent with the results obtained from an unweighted polygenic score 21 (Methods).
23
Given the sex-dimorphism of fat distribution in humans, previously shown to have a genetic basis (5, 24 17), we next performed meta-analyses of WHRadjBMI in women and men separately ( Table 1 and 25 Supplementary Fig 5) . We found SNP-based heritability (ℎ " 2 ) of WHRadjBMI, estimated using the 26 restricted maximum likelihood method implemented in BOLT-REML (10) (Methods), to be stronger in 27 women (ℎ " 2 = 25.6%) compared to men (ℎ " 2 = 16.7%, pdifference = 9 x 10 -85 ; Table 1 , Supplementary Table   28 6, and Equation 2). In addition to the heritability dimorphism, and in keeping with previous studies 29 (5), we found signatures of sex-dimorphism amongst associated loci: a total of 266 loci associated with 30 WHRadjBMI in women, compared to 91 loci in men (p < 5 x 10 -9 ). Genome-wide, SNP effects on
31
WHRadjBMI were strongly correlated between men and women (LD Score rg = 0.514 (s.e. = 0.019), p = 32 3.43 x 10 -159 ), but the consistency between the effect size of 266 female index SNPs on WHRadjBMI in 33 women and men (slope = 0.31; p = 2 x 10 -33 ; adjusted R 2 = 51%) was greater than the consistency 34 between the effect size of 91 male index SNPs on WHRadjBMI in men and women (slope = 0.20; p = 35 0.002; adjusted R 2 = 9%). Of all associated index SNPs (p < 5 x 10 -9 in the combined or sex-specific 36 analyses), 105 SNPs were sex-dimorphic (pdiff < 3.3 x 10 -5 ; (17) and Methods). Variants discovered in the 37 5 combined sex analysis will be enriched for those with similar effects in each sex, while variants 1 discovered in sex-specific analyses will be enriched for those with differing effects between sexes. In 2 the absence of any sex-specific effects, we would only expect a slight shift towards stronger 3 associations in women due to the larger available sample size in that analysis. However, we observed 4 that of the 105 sex-dimorphic signals, 97 (92.4%) showed stronger effects in women compared to men 5 (Figure 1, Supplementary Fig 6, and Methods). Scanning genome-wide for sex-dimorphic SNPs (pdiff < 5 6
x 10 -9 ), regardless of their association p-values in the sex-specific analyses, we identified 61 such SNPs, 7 54 (88.5%) of which had stronger effect in women than in men (Supplementary Information).
9
Previous studies have shown that in addition to redistributing body fat, some WHRadjBMI variants are 10 also associated with total body fat percentage (BF%) (5, (18) (19) (20) . Of relevance to the biology of adipose 11 tissue storage capacity, these studies have shown that these pleiotropic associations can occur in both 12 directions: some alleles associated with higher WHRadjBMI are associated with higher total BF%, whilst 13 others are associated with lower BF% (5, (18) (19) (20) 
18
whilst 34 SNPs associated with higher WHR but lower BF% (Figure 2) . Additionally, a large proportion 19 (29%) of WHRadjBMI index SNPs with a stronger effect in women had a BF% phenotype in men: 28 of the 20 97 female-specific WHRadjBMI SNPs were associated with BF% in men and 25 were associated with BF% 21 in women (p < 0.05/105 = 4.8 x 10 -4 , Supplementary Fig 7) . These variants appear to alter total BF% in 22 men and women to a similar extent but distribute body fat between the upper and lower body to a 23 much greater extent in women ( Supplementary Table 7 -9 and Supplementary Fig 7) . Finally, we 24 tested the index SNPs from each of the meta-analyses (combined and sex-specific) in a recent GWAS of 25 CT and MRI image-based measures of ectopic and subcutaneous fat depots (21). Adjusting for the three 26 sample groups and the 8 depots examined in the imaging-based GWAS (p < 0.05/24 = 2.1 x 10 -3 ), the 27 alleles associated with higher WHRadjBMI were collectively associated with lower measures of 28 subcutaneous fat, and higher measures of visceral fat, including pericardial and visceral adipose tissue
29
( Supplementary Fig 8) .
31
While we have performed the largest meta-analysis of a measure of body-fat distribution to date, a 32 number of limitations remain. First, the substantially larger number of signals with a stronger effect in 33 women compared to men may be influenced by the reduction in power (proportional to the product of 34 sample size and SNP heritability) in the men-only analysis ( too small (~1% of the discovery) to formally replicate individual SNP associations, but the fact that 78% 1 of the 300 previously unknown index associations showed consistent direction of effect suggests a low 2 false positive rate. Finally, our meta-analysis focused only on European-ancestry samples. Given the 3 very different body-fat distributions between people of European and non-European ancestry, and their 4 very different risks of adiposity-related disease, studies in non-Europeans are urgently needed (22,23).
6
In summary, the genetic variants and loci identified by this meta-analysis will likely provide starting 7 points for further understanding the biology of body fat distribution and its relationship with disease.
7 Tables and Figures   1 2 Table 1 | Large-scale meta-analysis in body fat distribution. We performed a meta-analysis of fat 3 distribution as measured by WHRadjBMI in up to 694,649 individuals. We performed analyses of WHR as 4 a sensitivity measure. Our analyses increase the number of WHRadjBMI-associated loci (p < 5 x 10 -9 , to 5 account for SNP density in UK Biobank) to 346 loci. SNP-based heritability (ℎ " 2 ) results, estimated using 6 the restricted maximum likelihood method implemented (10) Fig 9) , and used these normalized residuals as the tested phenotype in downstream 20 genome-wide association testing. To generate phenotypes for the sex-specific analyses, we followed 21 this same procedure but ran the regressions in sex-specific groups.
23
III. Genome-wide association analyses
24
The UK Biobank data 25 26
We conducted genome-wide association testing in the second release (June 2017) version of the UK
27
Biobank data(8); this release did not contain the corrected imputation at non-Haplotype Reference
28
Consortium (HRC (25)) sites and we therefore subset all of the SNP data down to HRC SNPs only. The UK
29
Biobank applied quality control to samples and genotypes and imputed the resulting genotype data 30 using sequencing-based imputation reference panels. We performed all of our genome-wide association 31 testing and downstream analyses on the publicly-available imputation data (released in bgen format).
33
We excluded samples as suggested by the UK Biobank upon release of the data ( Supplementary Table   34 11). Sample exclusions included samples with genotype but no imputation information, samples with 6 scores per SNP, calculated using LD Score Regression (12); and genotype data used to approximate a 7 genetic relationship matrix (GRM), which is the best method available in this sample size to account for 8 all forms of relatedness, ancestral heterogeneity in the samples, and other (potentially hidden) 9 structure in the data.
11
We performed sensitivity testing (Supplementary Information, Supplementary Tables 12-13 and 12 Supplementary Fig 10) using three LD Score reference datasets and four SNP-sets to construct the 13 GRM. For our final GWAS, we used LD scores calculated from a randomly-selected, 9,748 unrelated UK Fig 11-12) ; we did not run association testing using a non-28 infinitesimal model. The only covariate used in the LMM was the SNP array used to genotype sample;
29
we included no other covariates.
31
After association testing, we looked at known SNPs already reported in WHR, WHRadjBMI, and BMI (5, 32 24). At the previously-described loci, we checked correlation of frequency, beta, standard error, and -33 log10(p-value) between our UK Biobank GWAS and the previous GWAS results (Supplementary Fig 13) .
34
Additionally, we estimated genomic inflation (lambda) and the LD Score Intercept to check if the P-
35
values were well calibrated (Supplementary Table 2) ; calculations were performed using the LD Score data and UK Biobank were lifted over to their dbSNP151 identifier. We additionally renamed markers as 8 "rsID:A1:A2" (where A1 was the tested allele in UK Biobank) to avoid ambiguity at multiallelic SNPs in 9 the UK Biobank data. As the GIANT data was imputed with HapMap 2 (26,27) data (hg18), we 10 additionally lifted chromosomal positions to hg19 for this data. SNPs with a frequency difference > 15% 11 between GIANT and UK Biobank were removed from the data (Supplementary Fig 14) .
13
Meta-analysis and downstream quality control 14 15
We performed inverse variance-weighted fixed effects meta-analysis in METAL (28). To estimate LD 16 score intercepts and genomic inflation (lambda) for the meta-analysis results, we first estimated LD 17 scores from the same samples used to estimate the LD score reference for BOLT-LMM. LD scores were 18 only estimated at high-quality SNPs (using the same criteria as used for SNPs included in the GRM in
19
BOLT-LMM, but without applying a MAF threshold; Supplementary Information) . We then calculated LD 20 Score Regression intercepts and lambda with the LDSC software (12).
22
As an additional quality control check, we reran all of our GWAS using two different subsets of the UK
23
Biobank samples: (1) the unrelated samples only, and (2) the unrelated white British samples only.
24
These subsamples were selected to test if our initial UK Biobank-wide GWAS was confounded by either 25 relatedness or ancestral heterogeneity. After running these GWAS, we meta-analyzed the results with 26 the existing GIANT summary-level data and checked the concordance of our signals (Supplementary 27 Fig 2-3) . Supplementary Information) . SNPs with missingness > 5% after 1 conversion or Hardy-Weinberg equilibrium p < 1 x 10 -7 were removed.
3
We then used the PLINK 'clumping' algorithm to select top-associated SNPs (p < 5 x 10 -9 ) and identify 4 all SNPs in LD (r 2 > 0.05) with the top associated SNP and ±5Mb away. We determined the genomic span 5 of each LD-based clump and added 1kb up-and downstream as buffer to the region. If any of these 6 windows overlapped, we merged them together into a single (larger) locus. As a sensitivity analysis, we 7 ran clumping also using a smaller genomic window to calculate LD (±2Mb); the results were effectively 8 unchanged, as <5 loci appeared independent using the ±2Mb window but were found to correlate using 9 ±5Mb windows. Therefore, we report loci using the ±5Mb window. We used an independent dataset EXTEND (7,721 individuals of European descent collected from South
22
West England, Supplementary Table 14 ) to validate our findings. We extracted the index SNPs from 23 the HRC imputed genotypes. To generate the WHRadjBMI variable, we regressed WHR on BMI, age, age-24 squared, sex and principal components 1-5. We then performed rank based inverse normalization on 25 the resulting residuals. We validated the findings in 3 steps:
27
(1) Directional consistency. We checked for directional consistency between the effect of index SNPs 28 on WHRadjBMI from the main meta-analysis and EXTEND. We performed linear regression of WHRadjBMI 29 on each individual SNP. We ensured all alleles were aligned to the WHRadjBMI increasing allele in the 30 original meta-analysis. We compared directions between all 346 index SNPs and then split these into 31 novel and known signals to determine the number of novel signals showing consistent directionality.
33
(2) Variance explained. We evaluated the proportion of variance explained by including all the index
34
SNPs into a linear regression model and calculated the adjusted R 2 . We performed these analyses using 35 the lm() function in R.
37 14
(3) Polygenic scores. We created a weighted polygenic score based on the 346 index SNPs associated 1 with WHRadjBMI. The weighted polygenic risk score (PRS) was calculated by summing the dosage of the 2 WHRadjBMI-increasing alleles (weighted by the effect size on WHRadjBMI from the meta-analysis). We 3 then performed linear regression to test the association between WHRadjBMI and the PRS in our 4 independent dataset.
6
To determine how likely 5% of individuals carrying the most number of WHRadjBMI increasing alleles 7 were to meet the World Health Organization (WHO) WHR threshold for metabolic syndrome (13) 8 compared to 5% carrying the least, we used the WHR reference levels of > 0.9 in men and > 0.85 in 9 women to define cases and WHR < 0.9 in men and < 0.85 in women to define controls. We excluded all 10 individuals with missing data leaving a sample size of 7,513. We took 5% of individuals (7,513 x 0.05 = 11 376) from the two ends of weighted PRS and coded them as 1 or 2 respectively. We tested for the Fig 15) , we tested all index signals found 20 in the WHRadjBMI analysis for evidence of collider bias (15, 32). To do this, we ran meta-analyses of 21 BMI and WHR using the UK Biobank samples and pre-existing summary-level data from GIANT (5, 24) 
22
(Supplementary Methods). We performed these meta-analyses using identical methods to the meta-23 analysis of WHRadjBMI.
25
Then, for each index SNP from the WHRadjBMI meta-analyses (combined as well as sex-specific) we 26 extracted the association results from the BMI and WHR meta-analyses ( Supplementary Fig 4) .
27
WHRadjBMI-associated SNPs with a stronger association for BMI than WHR show evidence of collider 28 bias or pleiotropy. We additionally looked at the effect size and direction of effect in BMI and WHR, 29 but whether the effects are from collider bias or pleiotropy cannot be determined from this data.
31
VIII. Identification of sex-dimorphic signals 32 33
We estimated correlation between WHRadjBMI in females and in males using bivariate LD Score
34
Regression analysis (12, 33) .
35 36 1 sex-specific data from the GIANT consortium. We identified the primary and secondary signals from 2 these meta-analyses using methods identical to those performed in the combined analysis. We tested 3 each primary and secondary signal for a sex-dimorphic effect by estimating the t-statistic: 
where se is the standard error and r is the genome-wide Spearman rank correlation coefficient 8 between SNP effects in females and males. We estimated the t-statistic and the resulting so-called pdiff 9 (p-value from a t-distribution with one degree of freedom (17)) as implemented in the EasyStrata 10 software (34).
12
We tested a total of 2,162 different index SNPs for sex-dimorphism; we tested all of the secondary 13 signals as well, but these signals are by definition in linkage disequilibrium with the index SNPs (and 14 therefore not independent). Given that we tested for sex-dimorphism at index SNPs in not only
15
WHRadjBMI but WHR and BMI as well, we performed a test at 1,502 distinct genomic loci. Therefore,
16
we set significance for sex-dimorphism at a Bonferroni-corrected p = 0.05/1,502 = 3.3 x 10 -5 .
18
SNPs were determined to have a stronger effect in women if they fell into one of the following We implemented all heritability calculations in BOLT-LMM.(10) We used the same genetic relationship 30 matrix (GRM) to estimate SNP-based heritability as we did to run our GWAS (see Genome-wide 31 association analyses). This GRM included 790,000 SNPs. Heritability was estimated using only the UK
32
Biobank samples, for which we had individual level data; these estimates are likely more accurate than those resulting from only summary-level data. We used Restricted Maximum Likelihood Estimation, 1 implemented as --reml in BOLT.
3
To test the impact of including lower-frequency SNPs in the heritability estimates, we constructed an 4 additional GRM identically as we had for association testing but including no minor allele frequency 5 threshold. This GRM included ~1.7M SNPs. Heritability analyses were calculated identically using this 6 GRM and --reml in BOLT.
8
To calculate whether heritability estimates in men and women were sex-dimorphic, we used the 9 following equation to generate a z-score: 
13
We then converted the z-scores to P-values using the following formula in the statistical programming 14 language and software suite R (version 3.4): 
25
SNP was associated with BF% (Figure 2) . To determine whether sex-specific WHRadjBMI index SNPs
26
have an adiposity phenotype, we took the 97 (female-specific) and 8 (male-specific) SNPs and 27 independently compared their effects on WHRadjBMI and BF% in men and women. To identify which 28 sex-dimorphic SNPs were strongly associated with BF% in men and women separately, we used a
29
Bonferroni-corrected P-value of 0.05/105 (4.8 x 10 -4 ) ( Supplementary Fig 7 and well as sex-specific), checked for allele consistency, aligned effects to the reference allele, and tested 3 for associations with the imaging based measures of subcutaneous and ectopic fat. We repeated these 4 analyses in men and women separately. The depots investigated in the imaging-based GWAS were: Hounsfield units (VATHU), ratio of VAT to SAT (VAT/SAT), and VAT adjusted for BMI (VATadjBMI).
9
We calculated Pearson's r correlations between z-scores in WHRadjBMI (calculated by dividing the SNP 10 beta by the standard error) and SNP z-scores reported in Chu et al (21). We evaluated significance of 11 the correlation by performing a t-test (implemented as cor.test() in R). Correlations were considered 12 significant if P-value < 0.05/3 sample groups/9 phenotypes = 1.9 x 10 -3 . 
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